CanSino Biologics Inc.
HKEX:6185.HK
20.8 (HKD) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 345.182 | 1,031.041 | 4,299.702 | 18.544 | 2.283 | 1.132 | 9.182 | 8.195 |
| Cost of Revenue
| 1,221.201 | 1,217.648 | 1,296.486 | 13.804 | 0.147 | 113.646 | 68.1 | 51.667 |
| Gross Profit
| -876.019 | -186.607 | 3,003.216 | 4.74 | 2.136 | -112.514 | -58.918 | -43.472 |
| Gross Profit Ratio
| -2.538 | -0.181 | 0.698 | 0.256 | 0.935 | -99.394 | -6.417 | -5.305 |
| Reseach & Development Expenses
| 637.987 | 778.257 | 878.718 | 428.485 | 151.747 | 113.646 | 68.1 | 51.667 |
| General & Administrative Expenses
| 294.452 | 278.067 | 231.813 | 82.875 | 62.786 | 20.605 | 3.188 | 1.807 |
| Selling & Marketing Expenses
| 353.395 | 266.613 | 105.818 | 16.562 | 5.287 | 0 | 0 | 0 |
| SG&A
| 647.847 | 544.68 | 337.631 | 99.437 | 68.073 | 20.605 | 3.188 | 1.807 |
| Other Expenses
| -0.335 | -60.975 | -14.995 | -82.859 | -15.612 | 0.1 | -1.773 | 13.402 |
| Operating Expenses
| 1,202.887 | 1,261.962 | 1,201.354 | 445.063 | 204.208 | 152.353 | 75.604 | 54.364 |
| Operating Income
| -2,035.182 | -1,368.742 | 1,911.612 | -440.323 | -202.072 | -138.578 | -63.796 | -52.686 |
| Operating Income Ratio
| -5.896 | -1.328 | 0.445 | -23.745 | -88.496 | -122.419 | -6.948 | -6.429 |
| Total Other Income Expenses Net
| -256.997 | 184.741 | 25.175 | 43.685 | 45.306 | 0.297 | -0.654 | 2.835 |
| Income Before Tax
| -1,978.884 | -1,184.001 | 1,936.787 | -396.638 | -156.766 | -138.281 | -64.45 | -49.851 |
| Income Before Tax Ratio
| -5.733 | -1.148 | 0.45 | -21.389 | -68.655 | -122.156 | -7.019 | -6.083 |
| Income Tax Expense
| -11.451 | -219.244 | 29.701 | -38.148 | -3.657 | -12.543 | -11.808 | -1.678 |
| Net Income
| -1,482.732 | -964.757 | 1,914.39 | -358.49 | -153.109 | -138.281 | -64.45 | -49.851 |
| Net Income Ratio
| -4.296 | -0.936 | 0.445 | -19.332 | -67.053 | -122.156 | -7.019 | -6.083 |
| EPS
| -6.01 | -3.91 | 7.74 | -1.55 | -0.75 | -0.63 | -0.3 | -0.23 |
| EPS Diluted
| -6.01 | -3.91 | 7.74 | -1.55 | -0.75 | -0.63 | -0.3 | -0.23 |
| EBITDA
| -1,688.528 | -1,029.168 | 1,976.988 | -402.969 | -137.95 | -138.805 | -67.769 | -45.127 |
| EBITDA Ratio
| -4.892 | -0.998 | 0.46 | -21.73 | -60.415 | -122.619 | -7.381 | -5.507 |